Loading
IARC estimates 47,944 new cancer cases and 26,459 cancer deaths in Morocco in 2024; the commonest new cancers are breast, trachea, bronchus and lung and colorectum. This page is assembled automatically from OnCo's data: 1 trial with a site there, 1 institution and 1 person, and says what OnCo does not yet hold.
| Site | New cases | Rate | OnCo page |
|---|---|---|---|
| Breast | 10,410 | 48.1 | Triple-negative breast cancer (TNBC), HR-positive / HER2-negative breast cancer, HER2-positive breast cancer |
| Trachea, bronchus and lung | 6,101 | 14.3 | Lung cancer (all types), Non-small-cell lung cancer, Small-cell lung cancer |
| Colorectum | 4,040 | 9.4 | Colorectal cancer |
| Prostate | 3,533 | 17.3 | Prostate cancer |
| Thyroid | 3,209 | 7.6 | Thyroid cancer |
| Cervix uteri | 2,228 | 10.2 | Cervical cancer |
| Non-Hodgkin lymphoma | 1,602 | 3.8 | Non-Hodgkin lymphoma (all types), Diffuse large B-cell lymphoma |
| Bladder | 1,559 | 3.6 | Bladder & urothelial cancer |
| Stomach | 1,440 | 3.4 | Gastric & gastro-oesophageal junction cancer |
| Pancreas | 1,119 | 2.6 | Pancreatic ductal adenocarcinoma |
| Site | Deaths | Rate | OnCo page |
|---|---|---|---|
| Trachea, bronchus and lung | 5,763 | 13.5 | Lung cancer (all types), Non-small-cell lung cancer, Small-cell lung cancer |
| Breast | 3,918 | 18.1 | Triple-negative breast cancer (TNBC), HR-positive / HER2-negative breast cancer, HER2-positive breast cancer |
| Colorectum | 2,068 | 4.8 | Colorectal cancer |
| Prostate | 1,348 | 6.6 | Prostate cancer |
| Stomach | 1,151 | 2.7 | Gastric & gastro-oesophageal junction cancer |
| Pancreas | 1,084 | 2.5 | Pancreatic ductal adenocarcinoma |
| Cervix uteri | 1,009 | 4.6 | Cervical cancer |
| Brain, central nervous system | 863 | 2.2 | Glioma & glioblastoma |
| Bladder | 860 | 2.0 | Bladder & urothelial cancer |
| Leukaemia | 730 | 1.8 | Acute myeloid leukaemia, Acute lymphoblastic leukaemia, Chronic lymphocytic leukaemia |
| Trial | Lead sponsor | ||||
|---|---|---|---|---|---|
IMpassion131 NCT03125902 | Phase 3 | Completed | Hoffmann-La Roche | 161 | 2024-03-26 |
Trial records in OnCo whose ClinicalTrials.gov entry lists at least one site in Morocco, captured 2026-10-07 to 2026-10-07. Recruiting first, then the most recently updated. The status is the study's overall status; whether a site in Morocco is open is on the registry page, under Contacts and Locations.
OnCo records approvals for United States, European Union, United Kingdom, Japan, China, Australia and India. Morocco is not one of them, so no approval in OnCo speaks for it. See the approvals by region matrix for what is held.
A deep dive for Morocco is ranked 22 of 60 in the country coverage queue (November 2026), which ranks countries without a page by cases, deaths, research output and population. Know a source? Suggest an edit.